Abstract
Sphingosine kinase 1 (SPHK1) is overexpressed in solid tumors and leukemia. However, the mechanism of SPHK1 overexpression by oncogenes has not been defined. We found that v-Src-transformed NIH3T3 cells showed a high SPHK1 mRNA, SPHK1 protein and SPHK enzyme activity. siRNA of SPHK1 inhibited the growth of v-Src-NIH3T3, suggesting the involvement of SPHK1 in v-Src-induced oncogenesis. v-Src-NIH3T3 showed activations of protein kinase C-α, signal transducers and activators of transcription 3 and c-Jun NH2-terminal kinase. Their inhibition suppressed SPHK1 expression in v-Src-NIH3T3, whereas their overexpression increased SPHK1 mRNA in NIH3T3. Unexpectedly, the nuclear run-on assay and the promoter analysis using 5′-promoter region of mouse SPHK1 did not show any significant difference between mock- and v-Src-NIH3T3. Furthermore, the half-life of SPHK1 mRNA in mock-NIH3T3 was nearly 15 min, whereas that of v-Src-NIH3T3 was much longer. Examination of two AU-rich region-binding proteins, AUF1 and HuR, that regulate mRNA decay reciprocally, showed decreased total AUF1 protein associated with increased tyrosine-phosphorylated form and increased serine-phosphorylated HuR protein in v-Src-NIH3T3. Modulation of AUF1 and HuR by their overexpression or siRNA revealed that SPHK1 mRNA in v-Src- and mock-NIH3T3 was regulated reciprocally by these factors. Our results showed, for the first time, a novel mechanism of v-Src-induced SPHK1 overexpression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akao Y, Banno Y, Nakagawa Y, Hasegawa N, Kim TJ, Murate T et al. (2006). High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation. Biochem Biophys Res Commun 342: 1284–1290.
Alvarez SE, Milstien S, Spiegel S . (2007). Autocrine and paracrine roles of sphingosine-1-phosphate. Trends Endocrinol Metab 18: 300–307.
Bektas M, Jolly PS, Müller C, Eberle J, Spiegel S, Geilen CC . (2005). Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expression. Oncogene 24: 178–187.
Blobel GA, Hanafusa H . (1991). The v-src inducible gene 9E3/pCEF4 is regulated by both its promoter upstream sequence and its 3′ untranslated region. Proc Natl Acad Sci USA 88: 1162–1166.
Bonhoure E, Pchejetski D, Aouali N, Morjani H, Levade T, Kohama T et al. (2006). Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1. Leukemia 20: 95–102.
Borner C, Guadagno SN, Hsiao WW, Fabbro D, Barr M, Weinstein IB . (1992). Expression of four protein kinase C isoforms in rat fibroblasts. Differential alterations in ras-, src-, and fos-transformed cells. J Biol Chem 267: 12900–12910.
Bromann PA, Korkaya H, Webb CP, Miller J, Calvin TL, Courtneidge SA . (2005). Platelet-derived growth factor stimulates Src-dependent mRNA stabilization of specific early genes in fibroblasts. J Biol Chem 280: 10253–10263.
Chen CY, Del Gatto-Konczak F, Wu Z, Karin M . (1998). Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 280: 1945–1949.
Chen CY, Gherzi R, Ong SE, Chan EL, Raijmakers R, Pruijn GJ et al. (2001). AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 107: 451–464.
Cussac D, Greenland C, Roche S, Bai RY, Duyster J, Morris SW et al. (2004). Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity. Blood 103: 1464–1471.
Dehm S, Senger MA, Bonham K . (2001). SRC transcriptional activation in a subset of human colon cancer cell lines. FEBS Lett 487: 367–371.
Dehm SM, Bonham K . (2004). SRC gene expression in human cancer: the role of transcriptional activation. Biochem Cell Biol 82: 263–274.
Doller A, Huwiler A, Muller R, Radeke HH, Pfeilschifter J, Eberhardt W . (2007). Protein kinase C alpha-dependent phosphorylation of the mRNA-stabilizing factor HuR: implications for posttranscriptional regulation of cyclooxygenase-2. Mol Biol Cell 18: 2137–2148.
Fawal M, Armstrong F, Ollier S, Dupont H, Touriol C, Monsarrat B et al. (2006). A ‘liaison dangereuse’ between AUF1/hnRNPD and the oncogenic tyrosine kinase NPM-ALK. Blood 108: 2780–2788.
Frame MC . (2004). Newest findings on the oldest oncogene; how activated src does it. J Cell Sci 117: 989–998.
French KJ, Schrecengost RS, Lee BD, Zhuang Y, Smith SN, Eberly JL et al. (2003). Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 63: 5962–5969.
Fritz G, Kaina B, Aktories K . (1995). The ras-related small GTP-binding protein RhoB is immediate-early inducible by DNA damaging treatments. J Biol Chem 270: 25172–25177.
Gartsbein M, Alt A, Hashimoto K, Nakajima K, Kuroki T, Tennenbaum T . (2006). The role of protein kinase C delta activation and STAT3 Ser727 phosphorylation in insulin-induced keratinocyte proliferation. J Cell Sci 119: 470–481.
Good PJ . (1992). A conserved family of elav-like genes in vertebrates. Proc Natl Acad Sci USA 92: 4557–4561.
Greulich H, Reichman C, Hanafusa H . (1996). Delay in serum stimulation of Erk activity caused by oncogenic transformation. Oncogene 12: 1689–1695.
Hanford DS, Glembotski CC . (1996). Stabilization of the B-type natriuretic peptide mRNA in cardiac myocytes by alpha-adrenergic receptor activation: potential roles for protein kinase C and mitogen-activated protein kinase. Mol Endocrinol 10: 1719–1727.
Karni R, Dor Y, Keshet E, Meyuhas O, Levitzki A . (2002). Activated pp60c-Src leads to elevated hypoxia-inducible factor (HIF)-1 alpha expression under normoxia. J Biol Chem 277: 42919–42925.
Kawamori T, Osta W, Johnson KR, Pettus BJ, Bielawski J, Tanaka T et al. (2006). Sphingosine kinase 1 is up-regulated in colon carcinogenesis. FASEB J 20: 386–388.
Kloss S, Srivastava R, Mulsch A . (2004). Down-regulation of soluble guanylyl cyclase expression by cyclic AMP is mediated by mRNA-stabilizing protein HuR. Mol Pharmacol 65: 1440–1451.
Kuo L, Chang HC, Leu TH, Maa MC, Hung WC . (2006). Src oncogene activates MMP-2 expression via the ERK/Sp1 pathway. J Cell Physiol 207: 729–734.
Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale JL, Gorospe M . (2004). Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J 23: 3092–3102.
Leclerc GJ, Leclerc GM, Barredo JC . (2002). Real-time RT–PCR analysis of mRNA decay: half-life of beta-actin mRNA in human leukemia CCRF-CEM and Nalm-6 cell lines. Cancer Cell Int 2: 1–5.
Liu H, Sugiura M, Nava VE, Edsall LC, Kono K, Poulton S et al. (2000). Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J Biol Chem 275: 19513–19520.
Lopez de Silanes I, Zhan M, Lal A, Yang X, Gorospe M . (2004). Identification of a target RNA motif for RNA-binding protein HuR. Proc Natl Acad Sci USA 101: 2987–2992.
Meyer S, Temme C, Wahle E . (2004). Messenger RNA turnover in eukaryotes: pathways and enzymes. Crit Rev Biochem Mol Biol 39: 197–216.
Murakami M, Ichihara M, Sobue S, Kikuchi R, Ito H, Kimura A et al. (2007). RET signaling-induced SPHK1 gene expression plays a role in both GDNF-induced differentiation and MEN2-type oncogenesis. J Neurochem 102: 1585–1594.
Nakade Y, Banno Y, T-Koizumi K, Hagiwara K, Sobue S, Koda M et al. (2003). Regulation of sphingosine kinase 1 gene expression by protein kinase C in a human leukemia cell line, MEG-O1. Biochim Biophys Acta 1635: 104–116.
Olivera A, Kohama T, Edsall L, Nava V, Cuvillier O, Poulton S et al. (1999). Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J Cell Biol 14: 545–558.
Pan YX, Chen H, Kilberg MS . (2005). Interaction of RNA-binding proteins HuR and AUF1 with the human ATF3 mRNA 3′-untranslated region regulates its amino acid limitation-induced stabilization. J Biol Chem 280: 34609–34616.
Park YJ, Park ES, Kim MS, Kim TY, Lee HS, Lee S et al. (2002). Involvement of the protein kinase C pathway in thyrotropin-induced STAT3 activation in FRTL-5 thyroid cells. Mol Cell Endocrinol 194: 77–84.
Patrone G, Puppo F, Cusano R, Scaranari M, Ceccherini I, Puliti A et al. (2000). Nuclear run-on assay using biotin labeling, magnetic bead capture and analysis by fluorescence-based RT–PCR. Biotechniques 29: 1012–1014, 1016–1017.
Qureshi SA, Cao XM, Sukhatme VP, Foster DA . (1991). v-Src activates mitogen-responsive transcription factor Egr-1 via serum response elements. J Biol Chem 266: 10802–10806.
Raineri I, Wegmueller D, Gross B, Certa U, Moroni C . (2004). Roles of AUF1 isoforms, HuR and BRF1 in ARE-dependent mRNA turnover studied by RNA interference. Nucleic Acids Res 32: 1279–1288.
Shih SC, Mullen A, Abrams K, Mukhopadhyay D, Claffey KP . (1999). Role of protein kinase C isoforms in phorbol ester-induced vascular endothelial growth factor expression in human glioblastoma cells. J Biol Chem 274: 15407–15414.
Sobue S, Hagiwara K, Banno Y, Tamiya-Koizumi K, Suzuki M, Takagi A et al. (2005). Transcription factor specificity protein 1 (Sp1) is the main regulator of nerve growth factor-induced sphingosine kinase 1 gene expression of the rat pheochromocytoma cell line, PC12. J Neurochem 95: 940–949.
Sobue S, Iwasaki T, Sugisaki C, Nagata K, Kikuchi R, Murakami M et al. (2006). Quantitative RT–PCR analysis of sphingolipid metabolic enzymes in acute leukemia and myelodysplastic syndromes. Leukemia 20: 2042–2046.
Stoeckle MY, Hanafusa H . (1989). Processing of 9E3 mRNA and regulation of its stability in normal and Rous sarcoma virus-transformed cells. Mol Cell Biol 9: 4738–4745.
Stofega MR, Yu CL, Wu J, Jove R . (1997). Activation of extracellular signal-regulated kinase (ERK) by mitogenic stimuli is repressed in v-Src-transformed cells. Cell Growth Differ 8: 113–119.
Taha TA, Hannun YA, Obeid LM . (2006). Sphingosine kinase: biochemical and cellular regulation and role in disease. J Biochem Mol Biol 39: 113–131.
Tezuka K, Denhardt DT, Rodan GA, Harada S . (1996). Stimulation of mouse osteopontin promoter by v-Src is mediated by a CCAAT box-binding factor. J Biol Chem 271: 22713–22717.
Turkson J, Bowman T, Adnane J, Zhang Y, Djeu JY, Sekharam M et al. (1999). Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Mol Cell Biol 19: 7519–7528.
Vlasova IA, McNabb J, Raghavan A, Reilly C, Williams DA, Bohjanen KA et al. (2005). Coordinate stabilization of growth-regulatory transcripts in T cell malignancies. Genomics 86: 159–171.
Wilson GM, Lu J, Sutphen K, Sun Y, Huynh Y, Brewer G . (2003). Regulation of A + U-rich element-directed mRNA turnover involving reversible phosphorylation of AUF1. J Biol Chem 278: 33029–33038.
Wilusz CJ, Wormington M, Peltz SW . (2001). The cap-to-tail guide to mRNA turnover. Nat Rev Mol Cell Biol 2: 237–246.
Xia P, Gamble JR, Wang L, Pitson SM, Moretti PA, Wattenberg BW et al. (2000). An oncogenic role of sphingosine kinase. Curr Biol 10: 1527–1530.
Xie W, Herschman HR . (1995). v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor. J Biol Chem 270: 27622–27628.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)
Supplementary information
Rights and permissions
About this article
Cite this article
Sobue, S., Murakami, M., Banno, Y. et al. v-Src oncogene product increases sphingosine kinase 1 expression through mRNA stabilization: alteration of AU-rich element-binding proteins. Oncogene 27, 6023–6033 (2008). https://doi.org/10.1038/onc.2008.198
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2008.198
Keywords
This article is cited by
-
Integrative roles of sphingosine kinase in liver pathophysiology
Toxicological Research (2023)
-
Lysophosphatidate Promotes Sphingosine 1-Phosphate Metabolism and Signaling: Implications for Breast Cancer and Doxorubicin Resistance
Cell Biochemistry and Biophysics (2021)
-
Essential Roles of RNA-binding Protein HuR in Activation of Hepatic Stellate Cells Induced by Transforming Growth Factor-β1
Scientific Reports (2016)
-
Simultaneous oral and inhalational intake of molecular hydrogen additively suppresses signaling pathways in rodents
Molecular and Cellular Biochemistry (2015)
-
Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway
Breast Cancer Research (2014)